Schrödinger, Inc. (SDGR)
USD 17.97
(-1.32%)
USD 17.97
(-1.32%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -177.44 Million USD | -18.99% |
| 2022 | -149.12 Million USD | -33.81% |
| 2021 | -111.44 Million USD | -82.95% |
| 2020 | -60.91 Million USD | -57.34% |
| 2019 | -38.71 Million USD | -38.42% |
| 2018 | -27.96 Million USD | -47.04% |
| 2017 | -19.02 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -52.72 Million USD | 21.81% |
| 2024 Q1 | -67.43 Million USD | -127.65% |
| 2023 Q2 | -61.13 Million USD | -100.43% |
| 2023 Q4 | -29.62 Million USD | 47.29% |
| 2023 FY | -177.44 Million USD | -18.99% |
| 2023 Q1 | -30.5 Million USD | -6.88% |
| 2023 Q3 | -56.19 Million USD | 8.08% |
| 2022 Q4 | -28.53 Million USD | 38.18% |
| 2022 FY | -149.12 Million USD | -33.81% |
| 2022 Q1 | -28.64 Million USD | -27.22% |
| 2022 Q2 | -43.47 Million USD | -51.78% |
| 2022 Q3 | -46.16 Million USD | -6.19% |
| 2021 Q1 | -23.91 Million USD | -44.19% |
| 2021 Q4 | -22.51 Million USD | 35.07% |
| 2021 Q3 | -34.67 Million USD | -14.28% |
| 2021 Q2 | -30.34 Million USD | -26.89% |
| 2021 FY | -111.44 Million USD | -82.95% |
| 2020 Q1 | -11.8 Million USD | -50.38% |
| 2020 Q4 | -16.58 Million USD | -7.37% |
| 2020 Q3 | -15.44 Million USD | 9.61% |
| 2020 Q2 | -17.08 Million USD | -44.81% |
| 2020 FY | -60.91 Million USD | -57.34% |
| 2019 Q3 | -11.29 Million USD | 19.13% |
| 2019 Q2 | -13.96 Million USD | -148.76% |
| 2019 Q1 | -5.61 Million USD | 35.29% |
| 2019 FY | -38.71 Million USD | -38.42% |
| 2019 Q4 | -7.84 Million USD | 30.51% |
| 2018 Q1 | -4.58 Million USD | 0.0% |
| 2018 Q4 | -8.67 Million USD | 14.4% |
| 2018 Q2 | -9.09 Million USD | -98.6% |
| 2018 Q3 | -10.13 Million USD | -11.38% |
| 2018 FY | -27.96 Million USD | -47.04% |
| 2017 FY | -19.02 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Omnicell, Inc. | -34.86 Million USD | -408.914% |
| Renalytix Plc | -29.6 Million USD | -499.325% |
| Simulations Plus, Inc. | 6.13 Million USD | 2994.275% |
| SOPHiA GENETICS SA | -74.82 Million USD | -137.148% |
| Streamline Health Solutions, Inc. | -19.64 Million USD | -803.181% |
| BrightSpring Health Services, Inc. Common Stock | 147.18 Million USD | 220.565% |
| CareCloud, Inc. | -47.11 Million USD | -276.627% |
| HealthEquity, Inc. | 128.13 Million USD | 238.486% |
| iCoreConnect Inc. | -10.27 Million USD | -1626.719% |
| Inovalon Holdings, Inc. | 71.71 Million USD | 347.452% |
| Ontrak, Inc. | -20.67 Million USD | -758.273% |
| Minerva Surgical, Inc. | -30.89 Million USD | -474.284% |
| Nutex Health, Inc. | -31.77 Million USD | -458.474% |
| OneMedNet Corporation | -8.37 Million USD | -2018.972% |
| Progyny, Inc. | 62.18 Million USD | 385.36% |
| Augmedix, Inc. | -18.77 Million USD | -844.928% |
| CareCloud, Inc. | -47.11 Million USD | -276.627% |
| GE HealthCare Technologies Inc. | 2.43 Billion USD | 107.287% |
| Sharecare, Inc. | -96.47 Million USD | -83.932% |
| Aclarion, Inc. | -4.87 Million USD | -3539.227% |
| CareMax, Inc. | -656.15 Million USD | 72.956% |
| Bullfrog AI Holdings, Inc. Common Stock | -5.36 Million USD | -3205.956% |
| Forian Inc. | -5.59 Million USD | -3071.539% |
| Bullfrog AI Holdings, Inc. Warrants | -5.36 Million USD | -3205.956% |
| HeartBeam, Inc. | -15.31 Million USD | -1058.731% |
| GeneDx Holdings Corp. | -163.66 Million USD | -8.423% |
| SCWorx Corp. | -1.45 Million USD | -12132.208% |
| Definitive Healthcare Corp. | -329.8 Million USD | 46.195% |
| 10x Genomics, Inc. | -265.32 Million USD | 33.122% |
| Zhongchao Inc. | -13.28 Million USD | -1235.823% |
| Accolade, Inc. | -114.45 Million USD | -55.04% |
| MSP Recovery, Inc. | -559.87 Million USD | 68.305% |
| R1 RCM Inc. | 147.9 Million USD | 219.978% |
| Spok Holdings, Inc. | 21.22 Million USD | 935.915% |
| Privia Health Group, Inc. | 20.64 Million USD | 959.354% |
| EUDA Health Holdings Limited | -3.96 Million USD | -4379.818% |
| TruBridge, Inc. | -42.6 Million USD | -316.505% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 147.18 Million USD | 220.565% |
| Sharecare, Inc. | -96.47 Million USD | -83.932% |
| Health Catalyst, Inc. | -126.89 Million USD | -39.836% |
| GoodRx Holdings, Inc. | -27 Million USD | -557.044% |
| Premier, Inc. | 157.08 Million USD | 212.962% |
| HealthStream, Inc. | 16.01 Million USD | 1207.735% |
| Certara, Inc. | -40.77 Million USD | -335.199% |
| GeneDx Holdings Corp. | -163.66 Million USD | -8.423% |
| Ontrak, Inc. | -20.67 Million USD | -758.273% |
| SHL Telemedicine Ltd. | -9 Million USD | -1870.331% |
| CareCloud, Inc. | -47.11 Million USD | -276.627% |
| EUDA Health Holdings Limited | -3.96 Million USD | -4379.818% |
| HeartBeam, Inc. | -15.31 Million USD | -1058.731% |
| Mangoceuticals, Inc. | -9.21 Million USD | -1824.83% |
| CareMax, Inc. | -656.15 Million USD | 72.956% |
| Healthcare Triangle, Inc. | -11.34 Million USD | -1463.694% |
| National Research Corporation | 40.04 Million USD | 543.121% |
| Aclarion, Inc. | -4.87 Million USD | -3539.227% |
| OptimizeRx Corporation | -26.4 Million USD | -572.108% |